Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2008
Report date:
2008

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test type:
fixed dose procedure

Test material

Constituent 1
Chemical structure
Reference substance name:
1-({[(2,5-dioxopyrrolidin-1-yl)oxy]carbonyl}oxy)ethyl 2-methylpropanoate
EC Number:
700-402-2
Cas Number:
860035-10-5
Molecular formula:
C11H15NO7
IUPAC Name:
1-({[(2,5-dioxopyrrolidin-1-yl)oxy]carbonyl}oxy)ethyl 2-methylpropanoate

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
female

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
DMSO
Doses:
300mg/kg bodyweight
No. of animals per sex per dose:
5
Control animals:
no

Results and discussion

Effect levels
Sex:
female
Dose descriptor:
approximate LD50
Effect level:
> 300 - <= 2 000 mg/kg bw

Applicant's summary and conclusion

Interpretation of results:
harmful
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
The acute oral LD50 of the test material in female Sprague-Dawley rats was estimated to be in the range 300-2000mg/kg bw.
Executive summary:

Following a sighting test at dose levels of 300mg/kg and 2000mg/kg, a further group of four fasted female Sprague-Dawley CD strain rats were given a single oral dose of the test material, as a solution in DMSO ata dose level of 300mg/kg. Clinical signs and bodyweight development were moitored during the study.and all animals were subject to gross necrospy. The animal treated at 2000mg/kg was killed in extremis four hours after dosing and abnormalities at necropsy included haemorrhage and epithelial sloughing of the gastric mucosa. Signs of systemic toxicity noted during the observation period were hunched posture, lethargy, ataxia, gasping, laboured and noisy respiration. Two animals treated at 300mg/kg appreared normal throughout the observation period and the remaining animals in this group appeared normal one day after dosing. There were no deaths at 300mg/kg and the estimated oral LD50 was estimated to be between 300 -2000mg/kg.